Cubist Systematic Strategies’s Kezar Life Sciences KZR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-28,969
| Closed | -$710K | – | 2314 |
|
|
2023
Q2 | $710K | Buy |
28,969
+4,555
| +19% | +$112K | ﹤0.01% | 1286 |
|
|
2023
Q1 | $764K | Buy |
24,414
+22,308
| +1,059% | +$698K | ﹤0.01% | 1618 |
|
|
2022
Q4 | $148K | Sell |
2,106
-5,316
| -72% | -$374K | ﹤0.01% | 2749 |
|
|
2022
Q3 | $639K | Sell |
7,422
-2,034
| -22% | -$175K | ﹤0.01% | 2357 |
|
|
2022
Q2 | $782K | Buy |
9,456
+8,162
| +631% | +$675K | ﹤0.01% | 2287 |
|
|
2022
Q1 | $215K | Buy |
1,294
+34
| +3% | +$5.65K | ﹤0.01% | 2990 |
|
|
2021
Q4 | $211K | Buy |
+1,260
| New | +$211K | ﹤0.01% | 3004 |
|
|
2020
Q3 | – | Sell |
-1,490
| Closed | -$77K | – | 2562 |
|
|
2020
Q2 | $77K | Buy |
+1,490
| New | +$77K | ﹤0.01% | 2240 |
|
|
2019
Q2 | – | Sell |
-418
| Closed | -$74K | – | 2523 |
|
|
2019
Q1 | $74K | Buy |
+418
| New | +$74K | ﹤0.01% | 2046 |
|